<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Drug Safety on FinanClub</title>
    <link>https://finan.club/tags/drug-safety/</link>
    <description>Recent content in Drug Safety on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Tue, 08 Aug 2023 06:15:17 +0000</lastBuildDate><atom:link href="https://finan.club/tags/drug-safety/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title> APLS</title>
      <link>https://finan.club/us/apls/</link>
      <pubDate>Tue, 08 Aug 2023 06:15:17 +0000</pubDate>
      
      <guid>https://finan.club/us/apls/</guid>
      <description>score:964
Chances: Apellis Pharmaceuticals grants equity awards to new employees as part of the company&amp;rsquo;s employment inducement plan. Apellis reports better-than-expected second-quarter 2023 results, with significant growth in net product revenues. SYFOVRE shows promise in reducing GA lesion growth and demonstrates consistent safety profile in clinical studies.</description>
    </item>
    
  </channel>
</rss>
